Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabine.
Tsukahara S, Shiota M, Takamatsu D, Nagakawa S, Matsumoto T, Kiyokoba R, Yagi M, Setoyama D, Noda N, Matsumoto S, Hayashi T, Contreras-Sanz A, Black PC, Inokuchi J, Kohashi K, Oda Y, Uchiumi T, Eto M, Kang D.
Tsukahara S, et al. Among authors: nagakawa s.
Sci Rep. 2022 May 20;12(1):8535. doi: 10.1038/s41598-022-12528-3.
Sci Rep. 2022.
PMID: 35595780
Free PMC article.